Molecular model of gefitinib. Gefitinib is a new medicine; a selective inhibitor of the epidermal growth factor receptor's (EGFR) tyrosine kinase domain. It binds to the adenosine triphosphate (ATP) binding site of the enzyme and in this way inhibits the growth of malignant cells. C22 H24 Cl F N4 O3. Carbon in grey; Hydrogen in yellow; Nitrogen in orange; Chlorine in green; Fluorine in red; Oxygen in blue | |
Licence : | Droits gérés |
Crédit: | Science Photo Library / SciMAT |
Taille de l’image : | 3060 px × 1908 px |
Model Release : | Non requis |
Property Release : | Non requis |
Restrictions : |
|